Registered entities
Innovation
47 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 1,556 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 23 |
| 2023 | 24 |
| 2024 | 28 |
| 2025 | 19 |
| 2026 | 2 |
Social engagement
Social engagement: 8.2K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include Orbimed, PFM Health Sciences, Arch Venture Partners, City Hill; 6 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 6 | 40% |
| Other / undisclosed | 1 | 7% |
Hiring activity
Hires periodically
5 roles tracked across 3 of the last 12 months
17 Jun 2026 · Assoc Director/Director, Pharmaceutical Development · South San Francisco
11 Jun 2026 · Assoc Director, Director of Pharmaceutical Development
23 Mar 2026 · Clinical Scientist
10 Mar 2026 · Director, Clinical Pharmacology · San Diego
12 Dec 2025 · VP Global Pharmacovigilance · San Diego
Based on job postings tracked across public sources.